Figure 2: Changes in body weight from baseline to the end of treatment at week 26 associated with the treatment policy estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
The same 10mg vial reconstituted with 1ml yields 10mg/ml
None are better than another, or promote more weight loss or fewer side effects, so you can use whichever you prefer
When administered at therapeutic levels, APAP is primarily metabolized via the glucuronidation pathway, producing non-toxic metabolites that the liver and kidneys can further process (Chiew and Isbister 2023)
And it feeds the machinery that makes serotonin, so mood often tracks with it too
To be handled only by qualified professionals in controlled laboratory settings